# NOVEL B LACTAM ANTIBIOTICS

## Claims
Patentansprüche für folgende Vertragsstaaten BE, CH, DE, PR, GB, IT, LI, LU, NL, SE

## Description
This invention relates to a novel β lactam antibiotics, more particularly to a novel penicillin series and cephalosporin series antibiotics. Heretofore, it has been known that a β lactam series antibiotics has antibacterial activities to gram positive bacteria and gram negative bacteria and many of these compounds have actually been applied therefor. Among them, compounds which are called to as the third aged cephalosporin series antibiotics have wide range of antibacterial spectrum and particularly are evaluated in the clinical field. However, while the several kinds of the above compounds have been used in practical use, all of them are inferior in their antibiotical activities to Pseudomonas aeruginosa, Further, some kinds of them are finely effective to gram negative bacteria other than Pseudomonas aeruginosa but they have a disadvantage of lower activities to gram positive bacteria. GB A 1476312 discloses penicillin and cephalosporin derivatives in which the beta lactam ring has a side chain of the formula wherein R¹ is an alkyl, cycloalkyl, cycloalkenyl, aryl, substituted aryl, aralkyl or heterocyclic group R² is hydrogen or taken together with R¹ completes a carbocyclic or heterocyclic ring R³ and R⁴ are separately hydrogen or an alkyl, cycloalkyl, alkenyl, cycloalkenyl, aryl, aralkyl or heterocyclic group, any of which may be substituted, or R³ and R⁴ taken together complete a carbocyclic or heterocyclic ring R⁵ is an alkyl, cycloalkyl, aryl, aralkyl, or heterocyclic group, any of which may be substituted. US A 4091212 discloses alpha hydrazino carbonylamino cephalosporin derivatives having a side chain of the formula wherein R is hydrogen, lower alkyl, phenyl lower alkyl, diphenyl lower alkyl, trihaloethyl, tri lower alkyl silyl, tri lower alkyl stannyl or a salt forming ion of the group consisting of aluminum, alkali metal, alkaline earth metal, cyclo lower alkylamine, dicyclo lower alkylamine or lower alkylamine The present inventors have intensively studied, by referring to the above situation, concerning a compound which has potent activities in extremely wide ranges, and as a result, have found that the compound represented by the formula I has potent activities against gram negative bacteria including Pseudomonas aeruginosa and Serratia marcescens and other pathogenic bacteria as well as gram positive bacteria and accomplished the present invention. That is, the present invention comprises a β lactam compound represented by the formula wherein A is a group represented by the formulae where R₆ is a hydrogen atom or C₁ C₃ alkyl R¹ is hydrogen or a protecting group selected from formyl, trityl, chloroacetyl, t butoxycarbonyl, and 2,2,2 trichloroethoxycarbonyl R₂ is hydrogen, acetyl, propionyl, methoxy carbonyl or ethoxycarbonyl R₃ is hydrogen or methoxy X is hydrogen, hydroxyl, halogen, C₁ C₆ alkoxy, nitro or hydroxyl protected by acetyl, propionyl, methoxycarbonyl or ethoxycarbonyl n is 1 or 2 Y is a group represented by the formulae provided that the carbon atom attached to the COOM group is attached to the nitrogen atom of the beta lactam ring M is hydrogen, a protecting group selected from diphenylmethyl, t butyl, p nitrobenzyl and trimethylsilyl, or a group which is easily hydrolyzable in a human body and selected from acetoxymethyl, alpha acetoxyethyl, pivaloyloxymethyl, alpha ethoxycarbonyloxymethyl, alpha methoxycarbonyloxymethyl, alpha methoxycarbonyloxy ethyl, alpha ethoxycarbonyloxyethyl, 1 indanyl, phthalidyl, and 5 methyl 2 oxo 1,3 dioxol 4 yl methyl R₇ is hydrogen, methyl, C₂ C₇ alkoxymethyl or a group represented by the formula CH₂ T where T is C₂ C₃ alkanoyloxy, carbamoyloxy, quaternary ammonium derived from pyridine, 2 methyl pyridine, 3 methylpyridine, 4 methylpyridine, 4 ethylpyridine, 2,3 dimethylpyridine, 4 aminopyridine, 3 cyanopyridine, nicotinamide, isonicotinamide, 3 pyridine sulfonic acid, 4 pyridine ethanesulfonic acid, 3 hydroxypyridine, 4 hydroxypridine, nicotinicacid, isonicotinic acid, 5,6,7,8 tetrahydroisoquinoline, 5,6,7,8 tetrahydroquinoline, pyridazine, quinoline, isoquinoline, trimethylamine, triethylamine, N methylpiperidine, N methylpyrrolidine and N methylmorpholine, an unsubstituted 5 to 6 membered heterocyclic ring having 1 4 hetero atoms or a 5 to 6 membered heterocyclic ring having 1 to 4 hetero atoms in a ring substituted by at least one of C₁ C₃ alkyl, C₁ C₆ alkoxy, carboxymethyl, carboxyethyl, sulfoxymethyl, sulfoxyethyl, di C₁ C₃ alkyl amino ethyl, carboxy, amino, acetyl amino and hydroxy ethyl group, or T is of the formula are hydrogen atoms, or has the formula 0 B where the oxygen atom is bonded to nitrogen atom and B is a straight, or branched C₁ C₆ alkylene group or B is a cyclic alkylene group containing up to 6 carbon atoms where R₄ and R₅ are combined with each other to form an additional direct bond, or a pharmaceutically acceptable salt thereof, Preferably the said pharmaceutical acceptable of the beta lactam compound is an alkali metal, alkaline earth metal or ammonium salt or a salt, with an organic base, organic acid, or inorganic acid. said salt is a sodium, potassium, magnesium, calcium, diisopropylamine, benzylamine, triethanolamine, triethylamine, N methylmorpholine, pyridine, piperazine, acetic acid, formic acid, maleic acid, fumaric acid, methanesulfonic acid, p toluenesulfonic acid, hydrochloroic acid, hydrobromic acid, sulfuric acid or phosphoric acid salt. The following matters are also considered as a part of the invention The novel β lactam compounds and derivatives thereof to be intended in the present invention can be produced, roughly be mentioned, according to the following three methods. The title compound can be obtained by reacting the compound represented by the formula II wherein symbols in the formula are the same as mentioned above, wherein symbols in the formula are the same as mentioned above, In this method, the compound represented by the formula III which is used as a starting compound is a novel compound, and one of producing method of the title compound is shown by referring reaction schemes in the following wherein symbols in the formula are the same as mentioned above. wherein R₉ is a lower alkyl group or an aryl group and the other symbols are the same as mentioned above. The title compound can be obtained by reacting the compound represented by the formula IV wherein symbols in the formula are the same as mentioned above, wherein m is an integer of 0 or 1, and the other symbols are the same as mentioned above, In this method, the starting compound represented by the formula IV is a novel compound, and an example of the producing method is shown by referring reaction schemes in the following wherein R₁₀ is a protective group and the other symbols are the same as mentioned above. The compound represented by the formula I wherein T₁ represents a quaternary ammonium or S R₈ and the other symbols are the same as mentioned above, wherein J represents a halogen atom or an acetoxy group and the other symbols are the same as mentioned above, In the following, producing methods of the novel β lactam antibiotics according to the present invention will be explained in more detail. The reaction between the compound II and the compound III should desirably be carried out, in general, by using reactive derivatives of the compound III as the compound III . As the reactive derivatives, there may be mentioned, for example, acid halides, mixed acid anhydrides, active esters and the like. Further, while free carboxylic acids can be used as such, suitable condensation reagent may desirably be used in this case. As the reagent, there may be employed, for example, N,N dicyclohexylcarbodiimide DCC , N,N carbonyldiimidazole, cyanuric chloride, Vilsmeier reagent and the like. Such reactions have been known in the field of penicillin chemistry, cephalosporin chemistry and peptide chemistry. These reactions are usually carried out in a suitable solvent such as dichloromethane, chloroform, tetrahydrofuran, dioxane, dimethylformamide, dimethylacetamide, acetonitrile, acetone, water or mixed solvents of the above. Treatments after the reaction can be carried out by the methods well known in the art such as separation, purification and the like. The reaction of the compound IV and is carried out by reacting them in water, methanol or ethanol at about 10 to 50 In case of employing it can be reacted as acid halides, mixed acid anhydrides or active esters, or suitable condensation reagents such as N,N dicyclohexylcarbodiimide DCC , N,N carbonyldiimidazole, cyanuric chloride, Vilsmeier reagent and the like can be employed. These reactions can be carried out at about 10 to 20 In case of employing the reaction can easily be proceeded in an inert solvent such as dimethylformamide, dimethylacetamide, dimethylsulfoxide, dichloromethane, chloroform, acetonitrile or a mixed solvent of the above at about 0 to 50 The thus obtained compound I can be easily separated and purified by the known method. When the compound V and a tertiary amine are reacted, the reaction is carried out in water in case of COOM being a free carboxylic acid or a its salt, and a catalyst is used if necessary. As the catalyst, there may be employed, for example, potassium thiocyanate, sodium thiocyanate, potassium bromide, sodium bromide and the like. The reaction is carried out at a temperature of 20 to 80 In case of COOM being ester and J being a halogen atom, the reaction is carried out by contacting a tertiary amine in an organic solvent. However, a part of the double bonds will transfer whereby isomer will likely be generated. The reaction of the compound V and R₈ SH is carried out by contacting them in water or a water soluble organic solvent such as acetone, methanol, ethanol, isopropanol, acetonitrile, etc. when COOM is a free carboxylic acid or its salt. This reaction is desirably carried out at around neutral of pH and the reaction system can be maintained at around neutral by properly adding alkaline compounds such as an alkali hydroxide, an alkali carbonate, an alkali hydrogencarbonate, an alkali dihydrogenphosphate, an alkali monohydrogenphosphate, etc. The reaction temperature is generally about 20 to 70 In the present invention, the compound I obtained each methods of 1 , 2 and 3 as mentioned above can be converted into, if necessary, a pharmaceutically acceptable salt or an ester which is easily hydrolized in a human body when the compound has a free carboxylic acid. Thus, the compound of formula I obtained according to the present invention has high antibacterial activity as well as no toxicity at an effective dosage LD₅₀ value is 5 g kg or more when intravaneous administration to mouse is carried out and thus it is an effective compound as a medicine. For example, it shows excellent antibacterial activity against a wide range of pathogenic bacteria such as gram negative bacteria including Pseudomonas aeruginosa and gram positive bacteria. Accordingly, the β lactam compound according to the present invention can be effectively utilized for the sake of prevention or remedy of diseases due to the aforesaid pathogenic bacteria in human beings or animals. The β lactam compound according to the present invention can be administrated orally or non orally to human beings or animals by various administrating method. Further, said derivatives are used singly or formulating with auxiliaries, liquid diluents, binders, lubricants, humectants, etc., for example, in the form of general medicinal compositions such as tablets, granulars, sugar coating tablets, powder, capsules, gels, dry syrup, syrup, amples, suspension, liquid, emulsion, ointments, paste, cream, suppositorys, etc. Moreover, as the other additives which can be formulated, there may be mentioned dissolution delaying agents, absorption accelerating agents, surface active agents, etc. Any way, any forms which are pharmaceutially acceptable one can be employed. The β lactam compound according to the present invention can be used as alone or mixture of two or more different kinds of derivatives and the amount of the compounds is about 0.1 to 99.5 , preferably 0.5 to 95 based on the weight of the all medicinal composition. The medicinal composition according to the present invention can be formulated an other compounds which are pharmaceutically active as effective ingredients other than said novel β lactam compound or mixtures thereof. A dosage per day to a patient of the novel β lactam compound according to the present invention may be varied depending upon an individual man, kinds of animals, weights thereof and a state to be remedied, but generally is in the range of 1 to 1000 mg per 1 kg of weight, preferably about 10 to 800 mg. In the following, the present invention is eplained in detail by referring Examples. After colling 40 ml of methanol, 1.53 g 10 mmole of phosphorus oxychloride was added thereto and then to the mixture was added 3.4 g 4.62 mmole of 7 2 2 formylamino 1,3 thiazol 4 yl 2 3 formylcarbazoyl methoxy iminoacetamido 3 acetoxymethyl 3 cephem 4 carboxylic acid diphenylmethyl ester and stirred for one hour under ice cooling. The resulting mixture was added dropwise into 400 ml of ether while vigorously stirring and resulting precipitates were collected by filtration and dried to obtain 2.91 g of the title compound. Yield 83.7 In the same manner as in Reference example 1, dihidrochlorides of the compounds shown below can be obtained. The results are shown in Table 1. To an ice cooled mixture comprising 24 ml of trifluoroacetic acid and 6 ml of anisole was added 2.45 g 3.25 mmole of the compound obtained in Reference example 1 and stirredfor 30 minutes under ice cooling. The resulting mixture was added dropwise into 500 ml of ether while vigorously stirring and resulting precipitates were collected by filtration and dried to obtain 1.81 g of the title compound. Yield 95 In the same manner as in Reference example 8, dihydrides of the compounds represented by the following formulae were synthesized from the compounds obtained in Reference examples 3, 4 and 5, respectively. The results are shown in Table 2. In 10 ml of methanol were dissolved 0.88 g 1.5 mmole of 7 2 2 amino 1,3 thiazol 4 yl 2 carbozoylmethoxyiminoacetamido 3 acetoxymethyl 3 cephem 4 carboxylic acid dihydrochloride obtained in Reference example 8 and 0.249 g 1.8 mmole of 3,4 dihydroxybenzaldehyde and the mixture was stirred at room temperature for one hour. The resulting mixture was added dropwise into 200 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.85 g of the title compound. Yield 84.6 In the same manner as in Example 1, hydrochlorides of the β lactam compounds represented by the following formula were prepared. The results are shown in Table 3. In 30 ml of water was suspended 0.5 g of 7 2 2 amino 1,3 thiazol 4 yl 2 1 3 3,4 dihydroxybenzylidene carbozoyl ethoxyimino acetamido 3 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid hydrochloride obtained in Reference example 23 and the suspension was dissolved at pH about 7.5 by adding an aqueous 5 sodium hydrogencarbonate solution. After filtration thereof, the filtrate was adsorbed by 100 ml of HP 20 column filled with water and washed with water and 20 methanol water solution. Then, the title compound was eluted by 50 ethanol water solution, and after evaporation of methanol and lyophilized to obtain 0.2 g of the title compound. In 3 ml of methylene chloride was suspended 0.35 g 0.53 mmole of 7 2 2 amino 1,3 thiazol 4 yl 2 carbazoylmethoxyiminoacetamido 3 5 methyl 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid dihydrochloride obtained in Reference example 9 and the suspension was dissolved by adding 1.35 g 6.66 mmole of N,O bis trimethylsilyl acetamide. To the mixture was added 0.136 g 0.53 mmole of 3,4 diacetoxybenzoic acid chloride and the mixture was stirred at room temperature for one hour. The mixture was poured into 200 ml of ether and added thereto a small amount of methanol while stirring. The resulting precipitates were collected by filtration, washed with water and then dried to obtain 0.42 g of the title compound. Yield 94.1 In the same manner as in Example 36, hydrochlorides of the β lactam compounds represented by the following formula were synthesized. The results are shown in Table 4. 4 carboxylate In 10 ml of methanol was dissolved 0.4 g 0.505 mmole of 7 2 2 amino 1,3 thiazol 4 yl 2 3 3,4 diacetoxybenzoyl carbazoyl methoxyiminoacetamido 3 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid hydrochloride obtained in Example 37, and 0.15 ml of 25 aqueous ammonia was added thereto and the mixture was stirred at room temperature for one hour. To the resulting mixture was added 20 ml of ether and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.31 g of the title compound. Yield 86.7 In 2 ml of methylene chloride was suspended 0.257 g 0.39 mmole of 7 2 2 amino 1,3 thiazol 4 yl 2 carbazoylmethoxyiminoacetamido 3 5 methyl 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid dihydrochloride obtained in Reference example 9, and 1 g of N,O bis trimethylsilyl acetamide was added thereto to form a solution. To the resulting solution was added 0.22 g 0.84 mmole of 3,4 diacetoxybenzoylisocyanate and the mixture was stirred at room temperature for 8 hours. The resulting mixture was poured into 100 ml of ether and a small amount of methanol was added thereto while stirring. Resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.33 g of the title compound. Yield 84.6 Melting point 73 to 76 In the same manner as in Example 48 except for using 0.387 g 0.6 mmole of 7 2 2 amino 1,3 thiazol 4 yl 2 carbazoylmethoxyiminoacetamido 3 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid dihydrochloride obtained in Reference example 10, 4 ml of methylene chloride, 1 g 4.9 mmole of N,O bis trimethylsilyl acetamide and 0.332 g 1.26 mmole of 3,4 diacetoxybenzoylisocyanate, 0.49 g of the title compound was obtained. Yield 93.7 In 10 ml of methanol was dissolved 0.41 g 0.47 mmole of 7 2 2 amino 1,3 thiazol 4 yl 2 3 3,4 diacetoxybenzoyl carbamoyl carbazoyl methoxyiminoacetamido 3 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid hydrochloride obtained in Example 49, and 0.3 ml of 25 aqueous ammonia was added thereto and the mixture was stirred at room temperature for one hour. To the resulting solution was added 0.22 g 0.84 mmole of 3,4 diacetoxybenzoylisocyanate and the mixture was stirred at room temperature for 8 hours. To the resulting mixture was added 20 ml of ether and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.26 g of the title compound. Yield 70.3 In 50 ml of ice cooled methanol was added 5.21 g 34 mmole of phosphorus oxychloride, and then to the mixture was added 5.4 g 17.1 mmole of 2 2 formylamino 1,3 thiadiazol 4 yl 2 3 formylcarbazoyl methoxyiminoacetic acid and the mixture was stirred for one hour under ice cooling. The resulting mixture was added dropwise into 400 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 4.28 g of 2 2 amino 1,3 thiadiazol 4 yl 2 carbazoylmethoxyiminoacetic acid dihydrochloride. Yield 75.4 In 40 ml of methanol was dissolved 2.325 g 7 mmole of the above dihydrochloride, and 0.967 g 7 mmole of 3,4 dihyroxybenzaldehyde was added thereto and the mixture was stirred at room temperature for one hour. The resulting mixture was added dropwise into 400 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 2.20 g of the title compound. Yield 75.6 In 10 ml of DMF were dissolved 0.93 g 2.24 mmole of 2 2 amino 1,3 thiazol 4 yl 2 3 3,4 dihydroxybenzylidene carbazoyl methoxyiminoacetic acid hydrochloride obtained in Reference example 12 and 1.11 g 2.24 mmole of 7 amino 3 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid diphenylmethyl ester and the mixture was ice cooled, and 0.598 g 2.9 mmole of DCC was added thereto and stirred at room temperature for one hour. After filtration of the resulting mixture, to the filtrate was added the same amount of chloroform and the mixture was added dropwise into 400 ml of ether while vigorously stirring. Resulting precipitates were collected by filtration, washed with ether and then dried to obtain 2.36 g of the crude product. This product was purified through column chromatography 30 g of silica gel, eluent chloroform methanol formic acid 3 1 1 to obtain 1.13 g Yield 56.4 of aimed diphenylmethyl ester compound. A mixture comprising 8 ml of trifluoroacetic acid and 2 ml of anisole was ice cooled, and to the mixture was added 1.13 g 1.26 mmole of the diphenylmethyl ester obtained above and the mixture was stirred for 30 minutes. The resulting mixture was added dropwise into 150 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.89 g of the title compound as pale yellow powder. Yield 97.0 Physical properties thereof are accorded with those of the compound of Example 16. In 50 ml of methylene chloride was suspended 6.12 g 19.4 mmole of 2 2 amino 1,3 thiazol 4 yl 2 carbazoylmethoxyiminoacetic acid tert butyl ester, and to the suspension was added 20.8 g 102.3 mmole of N,O bis trimethylsilyl acetamide to form a solution. To the ice cooled solution was added 5.467 g 21.3 mmole of 3,4 diacetoxybenzoic acid chloride and the mixture was stirred for 2 hours under ice cooling. The resulting mixture was poured into 800 ml of ether and to the mixture was added a small amount of methanol while stirring. Resulting precipitates were collected by filtration, washed with ether and then dried to obtain 10.2 g of 2 2 amino 1,3 thiazol 4 yl 2 3 3,4 diacetoxybenzoyl carbazoyl methoxyiminoacetic acid tert butyl ester hydrochloride. Yield 98.2 In 100 ml of methanol was dissolved 5.69 g 10.6 mmole of the above hydrochloride, then 4.2 ml of 25 aqueous ammonia was added thereto and the mixture was stirred at room temperature for one hour. The resulting mixture was concentrated, and the residue was dissolved in 200 ml of 30 THF ethyl acetate, dried over anhydrous magnesium sulfate and then the solvent was distilled out after filtration. The resulting oily product was dissolved in 20 ml of trifluoroacetic acid and the solution was stirred at room temperature for 5 hours. Then, the resulting mixture was added dropwise into 400 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 3.9 g of trifluoroacetic acid salt of the title compound. To 20 ml of ice cooled methanol was added 3.1 g 20 mmole of phosphorus oxychloride, and 3.9 g of the previously obtained trifluoroacetic acid salt was added thereto and the mixture was stirred for 10 minutes. The resulting mixture was added dropwise into 400 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 3.4 g of the title compound. Yield 74.3 Melting point 157 to 159 In the same manner as in Reference example 13, hydrochlorides of the compounds represented by the following formula were prepared. The results are shown in Table 5. In the same manner as in Example 53, hydrochlorides of the β lactam compounds represented by the formula shown below were prepared. The results are shown in Table 6. In 10 ml of methylene chloride was suspended 0.659 g 2 mmole of 2 2 amino 1,3 thiazol 4 yl 2 1 carbazoylethoxyimino acetic acid tert butyl ester, and to the suspension was added 2.5 g 12.3 mmole of N,O bis trimethylsilyl acetamide to form a solution. To the ice cooled solution was added 0.565 g 2.2 mmole of 3,4 diacetoxybenzoic acid chloride and the mixture was stirred for 1.5 hours under ice cooling. The resulting mixture was poured into 150 ml of ether and to the mixture was added a small amount of methanol while stirring. Resulting precipitates were collected by filtration, washed with ether and then dried to obtain 1.05 g of 2 2 amino 1,3 thiazol 4 yl 2 1 3 3,4 diacetoxybenzoyl carbazoyl ethoxyimino acetic acid tert butyl ester hydrochloride. Yield 98.0 In 25 ml of methanol was dissolved 1.05 g 1.96 mmole of the above hydrochloride, then 0.96 ml of 25 aqueous ammonia was added thereto and the mixture was stirred at room temperature for 40 minutes. The resulting mixture was concentrated, and the residue was dissolved in 100 ml of 30 TXF ethyl acetate, dried over anhydrous magnesium sulfate and then the solvent was distilled out after filtration. The resulting oily product was dissolved in 5 ml of trifluoroacetic acid and the solution was stirred at room temperature for 2 hours. Then, the resulting mixture was added dropwise into 100 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.8 g of trifluoroacetic acid salt of the title compound. To 5 ml of ice cooled methanol was added 0.77 g 5 mmole of phosphorus oxychloride, and 0.8 g of the previously obtained trifluoroacetic acid salt was added thereto and the mixture was stirred for 10 minutes. The resulting mixture was added dropwise into 100 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.55 g of the title compound. Yield 62.9 Melting point 157 to 159 In 10 ml of methylene chloride was suspended 0.7 g 1.74 mmole of 2 2 amino 1,3 thiazol 4 yl 2 1 carbazoyl 1 methylethoxyimino acetic acid tert butyl ester, and to the suspension was added 2.16 g 10.6 mmole of N,O bis trimethylsilyl acetamide to form a solution. To the ice cooled solution was added 0.488 g 1.9 mmole of 3,4 diacetoxybenzoic acid chloride and the mixture was stirred for one hour under ice cooling. The resulting mixture was poured into 150 ml of ether and to the mixture was added a small amount of methanol while stirring. Resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.96 g of 2 2 amino 1,3 thiazol 4 yl 2 1 3 3,4 diacetoxybenzoyl carbazoyl 1 methylethoxyimino acetic acid tert butyl ester hydrochloride. Yield 97.9 In 25 ml of methanol was dissolved 0.96 g 1.7 mmole of the above hydrochloride, then 1 ml of 25 aqueous ammonia was added thereto and the mixture was stirred at room temperature for 30 minutes. The resulting mixture was concentrated, and the residue was dissolved in 100 ml of 30 THF ethyl acetate, dried over anhydrous magnesium sulfate and then the solvent was distilled out after filtration. The resulting oily product was dissolved in 10 ml of trifluoroacetic acid and the solution was stirred at room temperature for one hour. Then, the resulting mixture was added dropwise into 200 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.88 g of trifluoroacetic acid salt of the title compound. To 10 ml of ice cooled methanol was added 0.77 g 5 mmole of phosphorus oxychloride, and 0.88 g of the previously obtained trifluoroacetic acid salt was added thereto and the mixture was stirred for 10 minutes. The resulting mixture was added dropwise into 150 ml of ether while vigorously stirring and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.63 g of the title compound. Yield 80.6 In 20 ml of DMF were dissolved 3.15 g 10 mmole of 2 2 amino 1,3 thiazol 4 yl 2 carbazoylmethoxyiminoacetic acid, 1.66 g 12 mmole of salicylic acid and 1.62 g 12 mmole of 1 hydroxybenzotriazole. To the ice cooled solution was added 2.48 g 12 mmole of DCC, and the mixture was stirred for one hour after removal of a cooling bath. After filtration of the resulting mixture, the filtrate was dissolved in 200 ml of ethyl acetate and then washed with water followed by washing with a saturated saline solution. Then, filtration and evaporation of the solvent were carried out. After the residue was dissolved in 15 ml of trifluoroacetic acid and the mixture was stirred at room temperature for 3 hours, the resulting mixture was added dropwise into 500 ml of ether while vigorously stirring. Resulting precipitates were collected by filtration, washed with ether and dried to obtain the trifluoroacetic acid salt of the title compound. To 30 ml of ice cooled methanol were added 2.25 g 14.7 mmole of phosphorus oxychloride and then the trifluoroacetic acid salt obtained above, and the mixture was stirred for 10 minutes. The resulting mixture was added dropwise into 1.4 liters of ether while vigorously stirring, and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 4.02 g of the title compound. Yield 96.7 In 40 ml of DMF was dissolved 6.309 g 9.5 mmole of 7 2 2 formylamino 1,3 thiazol 4 yl 2 3 formylcarbazoyl methoxyiminoacetoamido 3 5 methyl 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid sodium salt and the mixture was ice cooled, and 4.88 g 20 mmole of 1 iododiethylcarbonate was added thereto and stirred at room temperature for 3 hours. To the resulting mixture was added 700 ml of ethyl acetate and the mixture was washed with water and then washed with a saturated saline solution, dried over anhydrous magnesium sulfate and the solvent was distilled out. The residue was purified through silica gel column chromatography eluent 5 to 10 methanol chloroform . To 30 ml of ice cooled methanol was added 0.92 g 6 mmole of phosphorus oxychloride and then pruified product through column, and the mixture was stirred for 1.5 hours under ice cooling. The resulting mixture was added dropwise into 800 ml of ether while vigorously stirring and resulting precipitates were collected by filtration and dried. After the resulting product was dissolved in 30 ml of methylene chloride and ice cooled, 25 ml 10 mmole of N,O bis trimethylsilyl acetamide was added thereto and the mixture was stirred for 10 minutes. Then, 0.9 g 3.5 mmole of 3,4 diacetoxybenzoic acid chloride was added thereto and the mixture was stirred for one hour under ice cooling. The resulting mixture was added dropwise into 800 ml of ether and resulting precipitates were collected by filtration, washed with ether and then dried to obtain 3.07 g of the title compound. Yield 35.5 In 70 ml of methylene chloride was suspended 2.159 g 5 mmole of 2 2 famino 1,3 thiazol 4 yl 2 3 3,4 dihydroxybenzoyl carbazoyl methoxyiminoacetic acid hydrochloride and the mixture was ice cooled, and then 3.49 g 25 mmole of triethylamine and 2.54 ml 20 mmole of trimethylchlorosilane TMCS were added thereto and stirred at room temperature for one hour to form a solution. The mixture was cooled to 40 To the resulting mixture was added a solution obtained by mixing 1.826 g 5 mmole of 7 amino 3 pyridiniummethyl 3 cephem 4 carboxylic acid betaine hydrochloride, 2.55 ml 10.4 mmole of N,O bis trimethylsilyl acetamide and 20 ml of methylene chloride and stirring them at room temperature for one hour, and the mixture was stirred for 1.5 hours while cooling with ice salt bath. The resulting mixture was poured into 200 ml of ice cooled water and stirred well. After distilled out the solvent, precipitates were removed by filtration. The filtrate was poured and adhered to a 500 ml of HP 20 column filled with water, washed with water and eluted by 50 methanol water. After condensation of fractions containing the title compound, condensate was lyophilized to obtain 0.3 g of the title compound. Yield 8.9 In the same manner as in Example 88, the compound shown below was obtained. 7 2 2 amino 1,3 thiazol 4 yl 2 1 3 3,4 dihydroxybenzoyl carbazoyl ethoxyimino acetamido 3 pyridiniummethyl 3 cephem 4 carboxylic acid betaine Yield 24.6 After a mixture comprising 1.679 g 2.5 mmole of 7 2 2 amino 1,3 thiazol 4 yl 2 3 3,4 dihydroxybenzoyl carbazoyl methoxyiminoacetamido 3 acetoxymethyl 3 cephem 4 carboxylic acid, 1.616 g 13 mmole of nicotinic acid, 4.5 g 30 mmole of sodium iodide, 0.086 ml of phosphoric acid, 1.5 ml of water and 5 ml of acetonitrile was stirred for 9 hours in a bath of 65 to 75 In the same manner as in Example 90, the compound shown by the following formula was prepared. The results are shown in Table 7. To 10 ml of ice cooled DMF was added 1.23 g 8 mmole of phosphorus oxychloride under stirring and stirring was continued at 40 To 5 ml of methanol were dissolved 0.4 g 0.754 mmole of 6 2 2 amino 1,3 thiazol 4 yl 2 carbazoylmethoxyiminoacetamido penicillanic acid dihydrochloride obtained in Reference example 26 and 0.11 g 0.8 mmole of 3,4 di hydroxybenzaldehyde and the mixture was stirred at room temperature for one hour. The resulting mixture was added dropwise into 150 ml of ether while vigorously stirring, resulting precipitates were collected by filtration, washed with ether and then dried to obtain 0.4 g of the title compound as a pale yellow powder. Yield 86.4 Melting point 177 to 183 In 200 ml of methylene chloride was suspended 5.8 g 13.43 mmole of 2 2 amino 1,3 thiazol 4 yl 2 3 3,4 dihydroxybenzoyl carbazoyl methoxyiminoacetic acid hydrochloride and the suspension was ice cooled, 9.4 ml 67.15 mmole of triethylamine and 6.82 ml of TMCS were added thereto and the mixture was stirred for one hour. After the resulting mixture was cooled to 40 A suspension comprising 6.44 g 0.1014 mole of N,N carbonyldiimidazole suspended in 70 ml of N,N dimethylformamide was stirred under ice cooling to set at 0 The resulting mixture was poured into 800 ml of water, neutralized with 2N hydrochloric acid to pH 4 and extracted five times with 200 ml of chloroform. The obtained extracts was washed three times with 300 ml of water, dried over anhydrous magnesium sulfate and distilled the solvent under reduced pressure. The resulting amorphous residue was ground with diisopropyl ether and filtrated to obtain 19.4 g Yield 74 of 2 2 formylamino 1,3 thiazol 4 yl 2 3 t butoxycarbonylcarbazoylamino acetic acid ethyl ester as a pale yellow crystal. Melting point 85 In 85.6 ml of 0.5 M aqueous sodium hydroxide solution was suspended 8.3 g 21.42 mmole of the compound obtained in Reference example 27, and the mixture was stirred at room temperature for 45 minutes. To the obtained mixture was added 150 ml of ethyl acetate, and the mixture was adjusted to pH 3 with the addition of 2N hydrochloric acid and an aqueous layer was extracted twice with 100 ml of ethyl acetate. The obtained organic layers were dried over anhydrous magnesium sulfate, the solvent was distilled under reduced pressure, and the residue was ground with ether, filtered and dried to obtain 6.99 g Yield 91 of 2 2 formylamino 1,3 thiazol 4 yl 2 3 t butoxycarbonylcarbazoylamino acetic acid as a white crystal. Melting point 121 To 20 ml of methanol was added 0.96 g 10.3 mmole of phosphorus oxychloride under ice cooling, and the mixture was stirred and set to 0 To 0.75 g 1.89 mmole of the product according to Reference example 29 was added 5.7 ml of a 1N aqueous sodium hydroxide solution and the mixture was stirred at room temperature for one hour. After dilution of the mixture with 20 ml of water, the mixture was neutralized with 2N hydrochloric acid and adjusted to pH 3, saturated by the addition of salt and extracted twice with 25 ml of tetrahydrofuran. The extracts were washed with 15 ml of a saturated saline solution, dried over anhydrous magnesium sulfate and evaporated to obtain residue. Ether was added to the residue to be powdered to obtain 0.35 g of the title compound. Yield 56 Melting point 123 After dissolving in 40 ml of THF a mixture comprising 2.00 g 5.565 mmole of the compound obtained in Reference example 28 and 0.752 g 5.565 mmole of 1 hydroxybenzotriazole, the solution was ice cooled to 10 During this stage, to 50 ml of methylene chloride suspension suspended 1.20 g 5.565 mmole of 6 APA was added 1.94 ml 13.9 mmole of triethylamine and the mixture was stirred at room temperature to form a solution. The resulting solution was added dropwise to the previously prepared mixture for 5 minutes and the mixture was stirred at 0 The resulting mixture was filtered, and the residue was washed with a small amount of THF. The filtrates were combined and evaporated, the residue was distributed to 100 ml of 2 aqueous sodium hydrogencarbonate solution and 70 ml of ethyl acetate, and was extracted with 30 ml of 2 aqueous sodium hydrogencarbonate solution further from the organic layer. The aqueous layers were combined, neutralized with 2N hydrochloric acid and adjusted to pH 3.5. The mixture was extracted twice with 100 ml of ethyl acetate, the extracts were dried over anhydrous magnesium sulfate and evaporated. To the residue of which a part was crystallized was added a mixed solution comprising 100 ml of ether and 100 ml of isopropyl ether, and insolubles were removed by filtration yielded 1.82 g of crude crystals containing 1 hydroxybenzotriazole. The thus obtained product was purified through silica gel column chromatography Silicagel 60 Merck 50 g by eluting it with chloroform methanol formic acid 50 5 2 to obtain 0.860 g of white crystals of monoformic acid salt of the title compound. Yield 25.6 To 0.800 g 1.44 mmole of the product obtained in Reference example 31 were added succesively 1 ml of anisole and 5 ml of trifluoroacetic acid and the mixture was stirred for one hour under ice cooling and further for one hour at room temperature. The resulting mixture was added dropwise into 100 ml of stirring ether, and precipitates were collected by filtration, vacuum dried to obtain 0.814 g of the title compound as its trifluoroacetic acid salt. Yield 99.3 Melting point 119 In 3 ml of methanol was dissolved 300 ml of the compound according to Reference example 32, and 109 mg 0.787 mmole of 3,4 dihydroxybenzaldehyde was added thereto at room temperature and the mixture was stirred for one hour at the same temperature. The resulting solution was added to 60 ml of ether while stirring, and precipitates were collected by filtration and vacuum dried to obtain 174 mg Yield 57.4 of the aimed white powder. Melting point 158 In 3 ml of methanol was added under ice cooling 0.20 ml 2.15 mmole of phosphorus oxychloride and the mixture was stirred for 5 minutes. Then, 130 mg 0.225 mmole of the compound according to Example 92 was added thereto and the mixture was stirred at the same temperature for one hour. The resulting mixture was added dropwise to 50 ml of ether while stirring, and precipitates were collected by filtration and vacuum dried to obtain 95 mg Yield 72.0 of the title compound as a white powder. Melting point 163 300 mg 0.905 mmole of the compound according to Reference example 30 and 397 mg 0.905 mmole of 7 ACA diphenylmethyl ester in 3 ml of DMF was stirred under ice cooling, and to the mixture was added 205 mg 0.996 mmole of DCC and stirred for one hour at the same temperature and further for one hour at room temperature. After a small amount of ethyl acetate was added thereto, the mixture was filtered to remove insolubles and washed with ethyl acetate. The filtrate and washing solution were combined and added dropwise into 150 ml of ether while stirring. Resulting precipitates were collected by filtration and vacuum dried to obtain 342 mg of the title compound as a pale orange powder. Yield 50.3 In 4 ml of DMF solution containing a mixture comprising 670 mg 1.86 mmole of the compound according to Reference example 28 and 952 mg 1.86 mmole of 7 amino 3 2 methyl 1,3,4 thiazol 5 yl thiomethyl 3 cephem 4 carboxylic acid diphenylmethyl ester was added under ice cooling 390 mg 1.89 mmole of N,N dicyclohexylcarbodiimide DCC and the mixture was stirred at the same temperature for 30 minutes and at room temperature for one hour. To the mixture was added 5 ml of ethyl acetate, the mixture was stirred for 5 minutes and then filtered to remove insolubles, and the residue was washed with a small amount of the same solvent. The filtrate and washing solution were combined and added dropwise into 170 ml of ether while stirring, and precipitated solids were collected by filtration and vacuum dried to obtain 1.39 g Yield 88 of a white powder of the title compound. Melting point 150 In the same manner as in Reference example 34, the compounds represented by the following formula were prepared. The results are shown in Table 8. After 15 ml of methanol was ice cooled to set 5 In the same manner as in Reference example 40 by treating the compounds according to Reference examples 35 to 39, the compounds represented by the following formula were prepared. The results are shown in Table 9. After 15 ml of trifluoroacetic acid and 3 ml of anisole were ice cooled to 0 In the same manner as in Reference example 46 by treating the compounds according to Reference example 33 and Reference examples 41 to 45, the compounds represented by the following formula were prepared. The results are shown in Table 10. To 3 ml methanol solution containing 200 mg 0.317 mmole of the compound obtained in Reference example 46 was added 50 mg 0.362 mmole of 3,4 dihydroxybenzaldehyde and the mixture was stirred at room temperature for 1.5 hours. The resulting mixture was added dropwise into 70 ml of ether while stirring, precipitated solids were collected by filtration and vacuum dried to obtain 195 mg Yield 86 of a white powder of the title compound. In the same manner as in Example 97, hydrochlorides of the β lactam compounds represented by the following formula were prepared. The results are shown in Table 11. In 6 ml of dried THF were dissolved 143 mg 0.60 mmole of 3,4 diacetoxybenzoic acid and 81 mg 0.60 mmole of 1 hydroxybenzotriazole, the mixture was ice cooled to maintain 0 To the resulting mixture was added 25 ml of THF and the mixture was stirred for 5 minutes and filtered to remove insolubles. The filtrate was added into 150 ml of ether while stirring and after 10 minutes stirring, precipitated solids were collected by filtration. The obtained residue was washed twice with 25 ml of methylene chloride and ether, respectively, and then vacuum dried to obtain 304 mg Yield 75 of a white powder of the title compound. Melting point 123 In 4 ml of dried methylene chloride was suspended 400 mg 0.634 mmole of the compound obtained in Reference example 46, and to the mixture was added 1.75 ml 7.17 mmole of N,O bis trimethylsilyl acetamide and the mixture was stirred at room temperatue for 30 minutes to obtain a transparent solution. To the solution was added 202 mg 0.789 mmole of 3,4 diacetoxybenzoylchloride at room tepmerature while stirring and stirring was continued at the same conditions for 45 minutes. The resulting mixture was added into 100 ml of ether and addition of 10 ml methanol thereto under stirring caused precipitation of solids. Ten minutes later, the precipitates were collected by filtration, and the residue was washed with ether and vacuum dried to obtain 427 mg Yield 83 of the title compound. This compound was accorded with the compound obtained in Example 109 in both of TLC and NMR. In the same manner as in Example 115, hydrochlorides of the β lactam compounds represented by the following formula were prepared. The results are shown in Table 12. In 3 ml methanol solution containing 385 mg 0.474 mmole of the compound obtained in Example 109 was added 0.38 ml of 25 aqueous ammonia and the mixture was stirred at room temperature for 2 hours. The resulting mixture was added into 100 ml of ether and the mixture was stirred for 10 minutes. Then, solids precipitated were collected by filtration, and the residue was vacuum dried to obtain 406 mg of crude powder. This powder was purified through silica gel column chromatography Silica gel 20 g, eluent CHCl₃ MeOH HCOOH 50 20 6 to obtain 115 mg Yield 32 of monoformix acid salt of the title compound. Melting point 193 In 100 ml of methylene chloride was dissolved 5.5 g 21.4 mmole of 2 amino 2 2 formylamino 1,3 thiazol 4 yl acetic acid tert butyl ester, and 2.165 g 21.4 mmole of triethylamine was added thereto. Then, the mixture was cooled to 45 In 30 ml ethanol was dissolved 7.5 g 21.0 mmole of 2 2 formylamino 1,3 thiazol 4 yl 2 ethoxalylaminoacetic acid tert butyl ester obtained in Reference example 53, 2.53 g 50 mmole of hydrazine hydrate was added thereto and the mixture was refluxed for one hour. After cooling, precipitates were collected by filtration, washed with ethanol and dried to obtain 5.42 g of the title compound. Yield 81.8 After stirring of a mixed solution comprising 3 ml of anhydrous acetic acid and 1.3 ml of formix acid at 55 In 20 ml of trifluoroacetic acid was dissolved 3.91 g 10.5 mmole of 2 2 formylamino 1,3 thiazol 4 yl 2 3 formylcarbazoyl carbonylaminoacetic acid tert butyl ester obtained in Reference example 55 and the mixture was stirred at room temperature for 3 hours. The resulting mixture was added dropwise into 250 ml of ether while vigorously stirring, and resulting precipitates were collected by filtration, washed with ether and dried to obtain 3.21 g of the title compound. Yield 97.0 In 30 ml of DMF were dissolved 3.1 g 9.8 mmole of 2 2 formylamino 1,3 thiazol 4 yl 2 3 formylcarbazoyl carbonylaminoacetic acid obtained in Reference example 56 and 4.867 g 9.8 mmole of 7 amino 3 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid diphenylmethyl ester, and to the mixture was added under ice cooling and stirring 2.476 g 12 mmole of DCC and the mixture was stirred for 30 minutes under ice cooling and further for one hour at room temperature. After filtration of the resulting mixture, to the filtrate was added the same amount of chloroform and the mixture was added dropwise into 700 ml of ether while vigorously stirring. Resulting precipitates were collected by filtration, washed with ether and dried to obtain 5.49 g of the title compound. Yield 70.6 Methanol 100 ml was ice cooled and 2.15 g of phosphorus oxychloride was added dropwise under stirring. To this mixture was added 5.49 g 6.91 mmole of 7 2 2 formylamino 1,3 thiazol 4 yl 2 3 formylcarbazoyl carbonylaminoacetamido 3 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid diphenylmethyl ester obtained in Reference example 57, and the mixture was stirred for 3 hours under ice cooling. After filtration of the resulting mixture, the filtrate was added dropwise into 700 ml of ether while vigorously stirring and precipitates were collected by filtration, washed with ether and dried to obtain 3.75 g of the title compound. Yield 66.9 . In 20 ml of methanol was dissolved 0.81 g 1 mmole of 7 2 2 amino 1,3 thiazol 4 yl 2 carbazoylcarbonylaminoacetamido 3 1,3,4 thiadiazol 2 yl thiomethyl 3 cephem 4 carboxylic acid diphenylmethyl ester dihydrochloride obtained in Reference example 58, and 0.138 g 1 mmole of 3,4 dihydroxybenzaldehyde was added thereto and the mixture was stirred at room temperature for one hour. After filtration of the resulting mixture, the filtrate was added dropwise into 250 ml of ether while vigorously stirring, and precipitates were collected by filtration, washed with ether and then dried to obtain 0.78 g of diphenylmethyl ester of the title compound. Yield 87.2 After a mixed solution comprising 4 ml of trifluoroacetic acid and 1 ml of anisole was ice cooled, 0.47 g 0.525 mmole of the previously obtained diphenylmethyl ester was added thereto and the mixture was stirred for 30 minutes under ice cooling. This mixture was added dropwise into 100 ml of ether while vigorously stirring and precipitates were collected by filtration, washed with ether and then dried to obtain 0.375 g of the title compound. Yield 98.1 After a mixture comprising 30 ml of trifluoroacetic acid and 10 ml of anisole was ice cooled, 3.87 g 10 mmole of the compound of Reference example 27 was added thereto while stirring and the mixture was stirred at the same temperature for 30 minutes and at room temperature for 18 hours. The resulting mixture was added dropwise into a mixed solution comprising 100 ml of ether and 150 ml of diisopropyl ether while stirring, and precipitated crystals were collected by filtration and vacuum dried to obtain 3.82 g Yield 95.2 of a white crystal of the title compound. In 30 ml of ethanol was added under ice cooling 1.77 ml 19.04 mmole of phosphorus oxychloride, and after the mixture was stirred for 5 minutes, 3.82 g 9.52 mmole of the compound according to Reference example 59 was added thereto at the same temperature and the mixture was stirred for 2 hours. The resulting mixture was added dropwise into 500 ml of ether while stirring, and precipitated crystals were collected by filtration and dried to obtain 2.45 g Yield 77.6 of the title compound as dihydrochloride. After 2.45 g 7.37 mmole of the compound according to Reference example 60 was suspended in 40 ml of methylene chloride, 9.01 ml 36.85 mmole of N,O bis trimethylsilyl acetamide was added thereto and the mixture was stirred for 30 minutes whereby the starting materials were dissolved completely. To the mixture was added 2.10 g 8.18 mmole of crystals of 3,4 diacetoxybenzoyl chloride and the mixture was stirred at room temperature for 50 minutes. After the mxiture was added into 400 ml of diisopropyl ether, 20 ml of methanol was added thereto while stirring so that white crystals were precipitated at once. These crystals were collected by filtration and vacuum dried to obtain 6.02 g of hydrochloride of the title compound containing acetamide. This compound was employed for the next reaction without further drying. In 37 ml of 1N aqueous sodium hydroxide solution was dispersed 6.02 g of crystals of 2 2 amino 1,3 thiazol 4 yl 2 3 3,4 diacetoxybenzoyl carbazoylamino acetic acid ethyl ester hydrochloride containing acetamide according to Reference example 61, and the mixture was stirred at room temperature for 1.5 hours. During stirring, crystals were dissolved completely. To this mixture was added 2N hydrochloric acid while stirring, and pH of the mixture was adjusted to 3.5. After further stirring for 10 minutes, precipitated crystals were collected by filtration, and the residue was washed well with water and vacuum dried over phosphorus pentoxide to obtain 1.36 g Yield 50.2 of pale yellow crystals of the title compound. In 9 ml of dried dimethylformamide was dissolved a mixture comprising 1.00 g 2.72 mmole of the compound obtained in Reference example 62 and 1.39 g 2.72 mmole of 7 amino 3 2 methyl 1,3,4 thiadiazol 5 yl thiomethyl 3 cephem 4 carboxylic acid diphenylmethyl ester, and 0.674 g 3.27 mmole of DCC was added thereto under ice cooling and stirring and the mixture was stirred at the same temperature for 30 minutes and at room temperature for 18 hours. After filtration of the mixture and the residue was washed with a small amount of dimethylformamide, the filtrate and washing were combined and added dropwise into 250 ml of ether while stirring. After 10 minutes stirring, precipitated solid was collected by filtration, washed well with ether and vacuum dried to obtain 1.96 g Yield 84 of pale yellow powder of the title compound. To 300 mg 0.349 mmole of the compound according to Example 117 were added successively 1 ml of anisole and 5 ml of trifluoroacetic acid and the mixture was stirred under ice cooling for one hour. The reaction mixture was added dropwise into 100 ml ether while stirring, and precipitated solids were collected by filtration, washed with ether and vacuum dried to obtain 295 mg Yield 91.7 of ditrifluoroacetic acid salt of the title compound as a pale yellow powder. This compound was confirmed that NMR data thereof were accorded with those of the compound obtained in Example 115. The minimun inhibition concentrations MIC of the compounds obtained by the present invention were measured according to the standard method of Japanese Chemotherapy Association. The results are shown in Tables 13 and 14. In Table 13, As comparative compounds, cephotaxim abbreviated to as CTX , cephazoline abbreviated to as CAZ , cephothiam abbreviated to as CTM and latamoxiceph abbreviated to as LMOX were used.